Pediatric
Clinical Specialties
Molecular Diagnostics Designed for Pediatric Care
Pediatricians need fast, accurate answers to guide treatment — especially when symptoms overlap, parents are anxious, and delaying the right therapy can impact recovery. Chronetyx provides high-speed, highly sensitive molecular testing designed to support clinical decision-making across common pediatric conditions.
We deliver next-day results on four key tests ideal for Pediatrics:
- Respiratory PCR
- Urine PCR (UTI) (with Antibiotic Resistance Detection)
- Wound PCR (with Antibiotic Resistance Detection)
- STI PCR
All tests are run on our fully automated PCR platform, ensuring exceptional accuracy and quick turn-around-times.
Why Pediatricians Partner With Chronetyx
Fast Results Support Better Outcomes
Pediatric illnesses often progress quickly. Our panels return actionable results within a day, helping providers treat early and avoid unnecessary antibiotics.
High Sensitivity for Young Patients
Children often show fewer or unusual symptoms and sometimes carry smaller amounts of pathogens, so advanced PCR testing helps ensure infections aren’t missed.
Single Swab / Simple Collections
Testing is designed to be gentle and easy:
• One swab for respiratory
• One urine sample for UTI
• Non-invasive STI testing (urine) when appropriate
Confidence for Parents
Parents want clear answers fast. Our molecular tests deliver easy-to-read reports that help reduce uncertainty and anxiety.
Unaffected by Prior Antibiotics
PCR remains effective, ensuring clinicians get accurate answers even in antibiotic pre-treated patients.
Competitive Pricing
Advanced molecular clarity without increased cost makes testing more accessible for practices and families alike.
Our Pediatric Panels
Respiratory PCR Panel
One quick swab. Answers in a day.
Respiratory illness is one of the most common reasons for pediatric visits. Our panel differentiates viral vs. bacterial causes and detects 16 common upper-respiratory pathogens, including RSV, Influenza A/B, Mycoplasma pneumoniae, Parainfluenza, and SARS-CoV-2.
Benefits:
- Helps guide treatment and reduce unnecessary antibiotics
- Supports better triage during peak viral seasons
- Faster clarity for concerned parents
- Helps guide return-to-school decisions
Urine PCR (UTI) Panel
Precise diagnosis — perfect for children who are unable describe symptoms clearly.
UTIs can escalate quickly in children. PCR identifies pathogens with far greater sensitivity than culture and detects resistance genes when organisms are present.
Benefits:
- Accurate even after partial antibiotic exposure
- Reflex antibiotic resistance testing included only when needed
- Helps prevent recurrent or complicated infections
STI PCR Panel
Fast, confidential, and clinically sensitive testing for adolescents.
Our panel detects Chlamydia, Gonorrhea, Trichomonas, and Mycoplasma genitalium with high accuracy.
Benefits:
- Non-invasive urine-based testing
- Supports early intervention and reduces transmission
- Appropriate workflows for adolescent care settings
Wound PCR Panel
Faster guidance for infected scrapes, bites, surgical wounds, and abscesses.
PCR identifies pathogens and antibiotic resistance genes up to 5 days faster than traditional culture, which is critical for children prone to rapid wound progression.
Benefits:
- Faster treatment decisions for cellulitis or non-healing wounds
- Detects polymicrobial infections which are common in children
- Reduces risk of unnecessary emergency room visits or hospitalizations
Why Chronetyx?
Automation-Driven Accuracy
Precise, reproducible results without human error.
Fast Turn-Around Times
Results in hours, not days — essential for pediatric care.
Local Laboratory & Support Team
Memphis-based testing ensures fast processing and reliable sample integrity.
Seamless EHR Integration
Clean, easy-to-interpret reports delivered directly to your system.
Better Answers for Better Pediatric Care
Pediatricians deserve diagnostics that match the pace and complexity of caring for children. Chronetyx delivers rapid, reliable molecular results that help clinicians treat earlier, reduce uncertainty, and improve outcomes — all with parent-friendly clarity and culture-comparable costs. This approach aids antibiotic stewardship, guiding timely, targeted treatment and reducing the spread of resistant pathogens like MRSA.